Many medical device companies develop a coverage and reimbursement strategy as a standalone model. Often, this strategy is developed to coincide with an expected product launch. But developing a reimbursement strategy in a silo can have enormous consequences. In this webinar, Tim Hunter will discuss the importance of integrating reimbursement strategy with the pre-market clinical trial (if required by the FDA) as well as with the FDA regulatory submission. Mr. Hunter also will outline key questions that medical device company executives should ask when reviewing a proposed reimbursement strategy.